Total
0
Shares
Imricor Medical Systems (ASX:IMR) completes heart surgery on patients in Germany
  • Imricor Medical Systems (IMR) has performed its first procedures using its products at the Heart Centre Dresden in Germany
  • Just last week the company received CE mark for its products
  • Three procedures were successfully performed over two days using the Vision-MR Ablation Catheter
  • CEO Steve Wedan says "It’s another tremendous milestone for Imricor"
  • On market close Imricor is down slightly, trading at $1.43 per share

Imricor Medical Systems (IMR) has performed its first procedures using its products at the Heart Centre Dresden in Germany.

Just last week, the company received its CE mark for Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Three procedures were successfully performed over two days by Dr. Christopher Piorkowski and Dr. Thomas Gaspar, using the Vision-MR Ablation Catheter.

The Vision-MR Ablation Catheter is the company’s prime product which is specifically designed to work under realtime MRI guidance.

It aims to have a higher success rate along with faster and safer treatment compared to conventional procedures using x-ray guided catheters.

These procedures mark the first iCMR (interventional cardiovascular magnetic resonance) ablations anywhere in the world to ever be performed outside of a clinical trial.

“It’s another tremendous milestone for Imricor,” said CEO Steve Wedan.

"It marks the beginning of routine clinical use and the coming of age for this exciting new field of iCMR," he added.

Over the past few months, the company has been working on developing a new imaging technique in the iCMR Design Centre. The technique is called Active Catheter Imaging.

The Active Catheter Imaging uses MR (magnetic resonance) imaging to easily identify the Vision-MR Ablation Catheter, without the use of active tracking or a mapping system.

The product proved to be highly effective in the procedures in Germany. Christopher commented during the procedure, “This is beautiful. It is better than fluoroscopy. In fluoroscopy, you can only imagine the anatomy. Here you see it.”

Active Catheter Imaging of the Vision-MR Ablation Catheter.
Image sourced Imricor

“Active Catheter Imaging is an exciting technique. It opens the door for more sites to start performing atrial flutter ablations guided by real-time MRI, without a
dependency on mapping system software or active tracking," Steve told the market.

"This will help support our iCMR lab adoption plans and timelines, and we will continue to lead the development of this new field through continued innovation," he said.

On market close Imricor is down slightly, trading at $1.43 per share.


Subscribe


IMR by the numbers
More From The Market Herald
Osprey Medical (ASX:OSP) - President & CEO, Mike McCormick - The Market Herald

" Osprey Medical (ASX:OSP) signs distribution deal with RHCG for DyeVert tech

Osprey Medical (OSP) has struck a deal to have its tech distributed and sold in Australia and New Zealand for the first time.
Incannex Healthcare (ASX:IHL) - Chief Medical Officer, Dr Sud Agarwal (left) & CEO, Joel Latham (right) - The Market Herald

" Incannex Healthcare (ASX:IHL) receives ethics approval for OSA trial

Medicinal cannabis company Incannex Healthcare (IHL) has received ethics approval for a phase 2b clinical trial investigating its obstructive sleep apnoea (OSA) treatment.
MyFiziq (ASX:MYQ) - CEO & Co Founder, Vlado Bosanac - The Market Herald

" MyFiziq (ASX:MYQ) JV completes $2M funding round

MyFiziq (MYQ) joint venture company, Body Composition Technologies, has completed a $2 million funding round.
Aperion Investment Group- Founder, Christian Angermayer - The Market Herald

" Bionomics (ASX:BNO) receives FIRB approval for Aperion’s 52pc stake

Bionomics (BNO) has received Foreign Investment Review Board (FIRB) approval for Aperion Investment Group to nab a 52 per cent stake in the